152 related articles for article (PubMed ID: 23577146)
21. The effects of RANTES/CCR5 promoter polymorphisms on HIV disease progression in HIV-infected Koreans.
Jang DH; Choi BS; Kim SS
Int J Immunogenet; 2008 Apr; 35(2):101-5. PubMed ID: 18218038
[TBL] [Abstract][Full Text] [Related]
22. The RANTES promoter polymorphism: a genetic risk factor for near-fatal asthma in Chinese children.
Yao TC; Kuo ML; See LC; Chen LC; Yan DC; Ou LS; Shaw CK; Huang JL
J Allergy Clin Immunol; 2003 Jun; 111(6):1285-92. PubMed ID: 12789231
[TBL] [Abstract][Full Text] [Related]
23. The VNTR polymorphism of the DC-SIGNR gene and susceptibility to HIV-1 infection: a meta-analysis.
Li H; Yu XM; Wang JX; Hong ZH; Tang NL
PLoS One; 2012; 7(9):e42972. PubMed ID: 22957026
[TBL] [Abstract][Full Text] [Related]
24. Chemokine MCP1/CCL2 and RANTES/CCL5 gene polymorphisms influence Henoch-Schönlein purpura susceptibility and severity.
Yu HH; Liu PH; Yang YH; Lee JH; Wang LC; Chen WJ; Chiang BL
J Formos Med Assoc; 2015 Apr; 114(4):347-52. PubMed ID: 25839768
[TBL] [Abstract][Full Text] [Related]
25. RANTES -28G delays and DC-SIGN - 139C enhances AIDS progression in HIV type 1-infected Japanese hemophiliacs.
Koizumi Y; Kageyama S; Fujiyama Y; Miyashita M; Lwembe R; Ogino K; Shioda T; Ichimura H
AIDS Res Hum Retroviruses; 2007 May; 23(5):713-9. PubMed ID: 17530998
[TBL] [Abstract][Full Text] [Related]
26. RANTES gene polymorphisms (-403G>A and -28C>G) associated with hepatitis B virus infection in a Saudi population.
Al-Qahtani A; Alarifi S; Al-Okail M; Hussain Z; Abdo A; Sanai F; Al-Anazi M; Khalaf N; Al-Humaidan H; Al-Ahdal M; Almajhdi FN
Genet Mol Res; 2012 Apr; 11(2):855-62. PubMed ID: 22576913
[TBL] [Abstract][Full Text] [Related]
27. The RANTES gene promoter polymorphisms are associated with the risk of atherothrombotic cerebral infarction in Northern Han Chinese.
Qin X; He Z; Zhao D; Li L; Yuan L
Clin Chim Acta; 2011 May; 412(11-12):1112-5. PubMed ID: 21376715
[TBL] [Abstract][Full Text] [Related]
28. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression.
Liu H; Chao D; Nakayama EE; Taguchi H; Goto M; Xin X; Takamatsu JK; Saito H; Ishikawa Y; Akaza T; Juji T; Takebe Y; Ohishi T; Fukutake K; Maruyama Y; Yashiki S; Sonoda S; Nakamura T; Nagai Y; Iwamoto A; Shioda T
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4581-5. PubMed ID: 10200305
[TBL] [Abstract][Full Text] [Related]
29. Protective effects of IL4-589T and RANTES-28G on HIV-1 disease progression in infected Thai females.
Wichukchinda N; Nakayama EE; Rojanawiwat A; Pathipvanich P; Auwanit W; Vongsheree S; Ariyoshi K; Sawanpanyalert P; Shioda T
AIDS; 2006 Jan; 20(2):189-96. PubMed ID: 16511411
[TBL] [Abstract][Full Text] [Related]
30. The Association between
Silva MJA; Marinho RL; Dos Santos PAS; Dos Santos CS; Ribeiro LR; Rodrigues YC; Lima KVB; Lima LNGC
Viruses; 2023 Sep; 15(9):. PubMed ID: 37766364
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms in the RANTES gene increase susceptibility to active tuberculosis in Tunisia.
Ben-Selma W; Harizi H; Bougmiza I; Ben Kahla I; Letaief M; Boukadida J
DNA Cell Biol; 2011 Oct; 30(10):789-800. PubMed ID: 21510799
[TBL] [Abstract][Full Text] [Related]
32. RANTES: a genetic risk marker for multiple sclerosis.
Gade-Andavolu R; Comings DE; MacMurray J; Vuthoori RK; Tourtellotte WW; Nagra RM; Cone LA
Mult Scler; 2004 Oct; 10(5):536-9. PubMed ID: 15471370
[TBL] [Abstract][Full Text] [Related]
33. TRIM5α H43Y Polymorphism and Susceptibility to HIV-1 Infection: A Meta-Analysis.
Deng J; Chen Y; Ding D; Lu P; Yang X; Song Z; Zhu H
AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1213-8. PubMed ID: 26398573
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-13 and RANTES polymorphisms in relation to asthma in children of Chinese Han nationality.
Liu Q; Hua L; Fang D; Lin Q; Zhu Y; Gan X; Bao Y
Asian Pac J Allergy Immunol; 2013 Sep; 31(3):247-52. PubMed ID: 24053708
[TBL] [Abstract][Full Text] [Related]
35. RANTES gene polymorphisms and asthma risk: A meta-analysis.
Zhang YG; Huang J; Zhang J; Li XB; He C; Xiao YL; Tian C; Wan H; Zhao YL; Tsewang YG; Fan H
Arch Med Res; 2010 Jan; 41(1):50-8. PubMed ID: 20430255
[TBL] [Abstract][Full Text] [Related]
36. Association of RANTES and MBL gene polymorphisms with systemic lupus erythematosus: a meta-analysis.
Xu WD; Peng H; Zhou M; Zhang M; Li BZ; Pan HF; Ye DQ
Mol Biol Rep; 2013 Feb; 40(2):941-8. PubMed ID: 23065234
[TBL] [Abstract][Full Text] [Related]
37. CCL5/RANTES chemokine gene promoter polymorphisms are not associated with atopic and nonatopic asthma in a Spanish population.
Muro M; Marín L; Torio A; Pagan JA; Alvarez-López MR
Int J Immunogenet; 2008 Feb; 35(1):19-23. PubMed ID: 18186796
[TBL] [Abstract][Full Text] [Related]
38. Association between CCL5, CCL11, and CCL17 polymorphisms and atopic dermatitis risk: A systematic review and meta-analysis.
Zou C; Zhang W; Li M; He D; Han Y; Liu M; Lu M
Medicine (Baltimore); 2024 Feb; 103(8):e36897. PubMed ID: 38394497
[TBL] [Abstract][Full Text] [Related]
39. A meta-analysis of the association between the CC chemokine ligand 5 (CCL5) -403 G>A gene polymorphism and tuberculosis susceptibility.
Areeshi MY; Mandal RK; Panda AK; Haque S
PLoS One; 2013; 8(8):e72139. PubMed ID: 24015211
[TBL] [Abstract][Full Text] [Related]
40. Polymorphisms in the promoter region of RANTES and the regulatory region of monocyte chemoattractant protein-1 among Chinese children with systemic lupus erythematosus.
Liao CH; Yao TC; Chung HT; See LC; Kuo ML; Huang JL
J Rheumatol; 2004 Oct; 31(10):2062-7. PubMed ID: 15468376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
